Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

deCODE genetics, Inc. (NASDAQ:DCGN.DL)

CAPS Rating: No stars

A biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DCGN.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

JOEYJP (< 20)
Submitted March 13, 2008

This company has the most advanced study for the human genome.

NetscribeBiotech (89.34)
Submitted January 15, 2007

deCODE genetics, Inc. operates as a biopharmaceutical company in the United States and Iceland. The firm created a database of Icelanders' gene samples, medical records, and genealogy records, some dating back to the ninth century. deCODE uses this… More

NASDAQ:DCGN.DL VS S&P 500 (SPY)

NASDAQ:DCGN.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about DCGN.DL.

No one has written a Pitch for DCGN.DL stock yet. Tell us why you think DCGN.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in DCGN.DL.

No players have picked DCGN.DL yet. Tell us why you think DCGN.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DCGN.DL.